FDA Says Yes to Marijuana for PTSD Study

Author:
Updated:
Original:
cannabis science

Sent to me by SF ASA:

FDA Says Yes to Marijuana for PTSD Study:

MAPS E-Mail Newsletter

May 9, 2011

Welcome to the May 2011 edition of the MAPS E-mail Newsletter.

On April 28, 2011, the Food and Drug Administration approved our planned study of marijuana for PTSD in veterans of war. This is a historic first for medical marijuana research, being the first time the FDA has approved an outpatient marijuana study. The next step is to convince the National Institute on Drug Abuse–a very different agency with explicitly political motivations and a monopoly on marijuana for research–to sell us the marijuana we need to conduct the study.

Meanwhile, our MDMA-assisted psychotherapy for PTSD research program is charging ahead. We're intensifying our fundraising efforts, expanding our range of research projects, and developing the world's first training program in psychedelic therapy.

I've lost count of how many committed and talented people have contacted MAPS to request information about how they can receive training in psychedelic therapy. A few times, I've had the privilege of meeting them in person. I've witnessed firsthand the hope and dedication in their eyes when they ask how they can help MAPS bring psychedelic healing to those traumatized by violence and disease.

As we prepare to move to the next phase of our drug development program, there will be more need for therapists trained in MAPS' approach to MDMA-assisted psychotherapy than ever before. And ultimately, the need for these skills will go far beyond the narrow context of clinical research. The establishment of legal psychedelic therapy clinics in the U.S. and elsewhere will require an entirely new generation of medical professionals trained in the techniques of psychedelic therapy.

We're planning not just for the future of MAPS, but for the future of psychedelic medicine worldwide.

Since 1986, MAPS has distributed over $12 million to psychedelic and medical marijuana research and education–every dollar of which has come from our members. Please donate today and help us share this knowledge with the next generation of healers.

Finally, I'm delighted to announce that the Spring 2011 Special Edition of the MAPS Bulletin on "Psychedelics and the Mind/Body Connection" is now available online and in members' mailboxes. With breathtaking visionary artwork and dozens of thought-provoking articles on everything from immunology and neuroscience to surfing and skydiving, this issue is sure to inspire.

Sincerely,

Brad Burge, M.A.
MAPS Director of Communications

Related